c-Met tyrosine kinase inhibitors (inno.N)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Namec-Met tyrosine kinase inhibitors (inno.N)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHepatocyte growth factor receptor inhibitors

TargetsHepatocyte growth factor receptor

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHK Inno N Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesHK Inno N Corp

Active IndicationsN/A

Inactive IndicationsStomach Neoplasms

ATC CodeN/A